Myeloproliferative neoplasm: Difference between revisions
CSV import |
No edit summary |
||
| Line 27: | Line 27: | ||
{{stub}} | {{stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
<gallery> | <gallery> | ||
File:Myelogram of person with a myeloproliferative disorder.png|Myeloproliferative neoplasm | File:Myelogram of person with a myeloproliferative disorder.png|Myeloproliferative neoplasm | ||
</gallery> | </gallery> | ||
Revision as of 00:46, 17 March 2025
Myeloproliferative neoplasms (MPNs) are a group of rare blood cancers in which excess red blood cells, white blood cells or platelets are produced in the bone marrow. The three main types of MPNs are polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
Symptoms
Symptoms of MPNs can vary greatly, depending on the specific type of MPN and the individual patient. Some people with MPNs do not have any symptoms at all. When symptoms do occur, they can include fatigue, shortness of breath, easy bruising or bleeding, and an enlarged spleen.
Causes
The exact cause of MPNs is not known. However, most people with these conditions have mutations in certain genes that affect blood cell production. The most common of these is the JAK2 gene.
Diagnosis
Diagnosis of MPNs typically involves blood tests to check for high levels of blood cells and bone marrow tests to look for abnormal cells. Genetic testing may also be done to look for mutations in the JAK2 gene or other genes.
Treatment
Treatment for MPNs depends on the specific type of MPN and the severity of the patient's symptoms. It may include medication to reduce blood cell production, procedures to remove excess blood cells, and in some cases, stem cell transplantation.
See also
References
<references />



